These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Pharmacokinetics of N-acetylprocainamide in patients profiled with a stable isotope method. Atkinson AJ; Ruo TI; Piergies AA; Breiter HC; Connelly TJ; Sedek GS; Juan D; Hubler GL; Hsieh AM Clin Pharmacol Ther; 1989 Aug; 46(2):182-9. PubMed ID: 2474402 [TBL] [Abstract][Full Text] [Related]
23. The quantitative disposition of procainamide and N-acetylprocainamide in the rat. Schneck DW; Grove K; Dewitt FO; Shiroff RA; Hayes AH J Pharmacol Exp Ther; 1978 Jan; 204(1):219-25. PubMed ID: 619132 [TBL] [Abstract][Full Text] [Related]
24. Clinical pharmacokinetics of N-acetylprocainamide. Connolly SJ; Kates RE Clin Pharmacokinet; 1982; 7(3):206-20. PubMed ID: 6178545 [TBL] [Abstract][Full Text] [Related]
26. Transport of procainamide and N-acetylprocainamide from blood into the intestinal lumen and intestinal dialysis by oral activated charcoal in rats with acute renal failure. Arimori K; Nakano M J Pharmacobiodyn; 1988 Jul; 11(7):504-11. PubMed ID: 2460613 [TBL] [Abstract][Full Text] [Related]
27. Famotidine, a new H2-receptor antagonist, does not affect hepatic elimination of diazepam or tubular secretion of procainamide. Klotz U; Arvela P; Rosenkranz B Eur J Clin Pharmacol; 1985; 28(6):671-5. PubMed ID: 2866097 [TBL] [Abstract][Full Text] [Related]
28. Use of procainamide in chronic ambulatory peritoneal dialysis: report of a case. Kroboth PD; Mitchum K; Puschett JB Am J Kidney Dis; 1984 Jul; 4(1):78-9. PubMed ID: 6204527 [TBL] [Abstract][Full Text] [Related]
29. Aging and renal clearance of procainamide and acetylprocainamide. Reidenberg MM; Camacho M; Kluger J; Drayer DE Clin Pharmacol Ther; 1980 Dec; 28(6):732-5. PubMed ID: 6160015 [TBL] [Abstract][Full Text] [Related]
31. Clinical pharmacokinetics of procainamide. Karlsson E Clin Pharmacokinet; 1978; 3(2):97-107. PubMed ID: 346289 [TBL] [Abstract][Full Text] [Related]
32. Circadian changes in procainamide and N-acetylprocainamide kinetics in the rat. Bruguerolle B; Jadot G J Pharm Pharmacol; 1985 Sep; 37(9):654-6. PubMed ID: 2416904 [TBL] [Abstract][Full Text] [Related]
33. N-Acetylprocainamide levels in patients with end-stage renal failure. Gibson TP; Matusik EJ; Briggs WA Clin Pharmacol Ther; 1976 Feb; 19(2):206-12. PubMed ID: 1261157 [TBL] [Abstract][Full Text] [Related]
34. Renal clearance of pyridostigmine in myasthenic patients and volunteers under the influence of ranitidine and pirenzepine. Eiermann B; Sommer N; Winne D; Schumm F; Maier U; Breyer-Pfaff U Xenobiotica; 1993 Nov; 23(11):1263-75. PubMed ID: 8310710 [TBL] [Abstract][Full Text] [Related]